Barclays’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $509K | Buy |
153,828
+70,871
| +85% | +$235K | ﹤0.01% | 3032 |
|
|
2025
Q1 | $241K | Sell |
82,957
-35,754
| -30% | -$104K | ﹤0.01% | 3227 |
|
|
2024
Q4 | $422K | Buy |
118,711
+19,399
| +20% | +$69K | ﹤0.01% | 3157 |
|
|
2024
Q3 | $495K | Buy |
99,312
+73,542
| +285% | +$367K | ﹤0.01% | 2995 |
|
|
2024
Q2 | $67K | Buy |
+25,770
| New | +$67K | ﹤0.01% | 3555 |
|
|
2023
Q4 | – | Sell |
-7,144
| Closed | -$11K | – | 4198 |
|
|
2023
Q3 | $11K | Buy |
+7,144
| New | +$11K | ﹤0.01% | 4008 |
|
|
2022
Q2 | – | Sell |
-24,829
| Closed | -$65K | – | 4693 |
|
|
2022
Q1 | $65K | Hold |
24,829
| – | – | ﹤0.01% | 3878 |
|
|
2021
Q4 | $97K | Sell |
24,829
-3,097
| -11% | -$12.1K | ﹤0.01% | 2965 |
|
|
2021
Q3 | $122K | Sell |
27,926
-3,456
| -11% | -$15.1K | ﹤0.01% | 3155 |
|
|
2021
Q2 | $125K | Buy |
31,382
+14,770
| +89% | +$58.8K | ﹤0.01% | 3063 |
|
|
2021
Q1 | $86K | Buy |
16,612
+10,197
| +159% | +$52.8K | ﹤0.01% | 3414 |
|
|
2020
Q4 | $34K | Sell |
6,415
-2,665
| -29% | -$14.1K | ﹤0.01% | 3292 |
|
|
2020
Q3 | $43K | Sell |
9,080
-23,262
| -72% | -$110K | ﹤0.01% | 3336 |
|
|
2020
Q2 | $156K | Buy |
+32,342
| New | +$156K | ﹤0.01% | 2934 |
|
|
2020
Q1 | – | Sell |
-159
| Closed | -$1K | – | 3639 |
|
|
2019
Q4 | $1K | Sell |
159
-652
| -80% | -$4.1K | ﹤0.01% | 3804 |
|
|
2019
Q3 | $2K | Buy |
811
+391
| +93% | +$964 | ﹤0.01% | 4001 |
|
|
2019
Q2 | $2K | Sell |
420
-5,441
| -93% | -$25.9K | ﹤0.01% | 4129 |
|
|
2019
Q1 | $40K | Buy |
+5,861
| New | +$40K | ﹤0.01% | 3732 |
|
|
2018
Q4 | – | Sell |
-1,956
| Closed | -$34K | – | 4078 |
|
|
2018
Q3 | $34K | Buy |
+1,956
| New | +$34K | ﹤0.01% | 3837 |
|